MFDS
- Marketing authorisation holder: AMGEN INC
- Status: likely_approved
🇰🇷 Imdelltra (Amg757) in South Korea
Imdelltra (Amg757) (TARLATAMAB) regulatory status in South Korea.
Marketing authorisation
Imdelltra (Amg757) in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Imdelltra (Amg757) approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Imdelltra (Amg757) in South Korea?
AMGEN INC holds the South Korean marketing authorisation.